Biotech · Private company
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Track this companyFree. Adds Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- MK-4208Phase 2 · Leukemia, Myelogenous, Chronic, BCR-ABL PositiveClinicalTrials.gov · fetched Nov 12, 2026
- TERN-101Phase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- TERN-501Phase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- TERN-601Phase 2 · Overweight or ObesityClinicalTrials.gov · fetched Nov 12, 2026
- DigoxinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- EmbibatinibPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MontelukastPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- PravastatinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- RabeprazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TERN-201Phase 1 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- TERN-701Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Clinical Trial to Evaluate [14C]-MK-4208/[14C]-TERN-701 in Healthy Adult Male Participants (MK-4208-002/TERN701-1016)PHASE1 · COMPLETED · started Feb 25, 2026ClinicalTrials.gov NCT07839000 · fetched Nov 12, 2026
- A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or ObesityPHASE2 · COMPLETED · started Mar 7, 2025ClinicalTrials.gov NCT06854952 · fetched Nov 12, 2026
- A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)PHASE1_PHASE2 · RECRUITING · started Mar 26, 2024ClinicalTrials.gov NCT06163430 · fetched Nov 12, 2026
- A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)PHASE1 · COMPLETED · started Dec 21, 2023ClinicalTrials.gov NCT07838987 · fetched Nov 12, 2026
- DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic SteatohepatitisPHASE2 · COMPLETED · started Jun 28, 2022ClinicalTrials.gov NCT05415722 · fetched Nov 12, 2026
- AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic SteatohepatitisPHASE1 · COMPLETED · started May 20, 2021ClinicalTrials.gov NCT04897594 · fetched Nov 12, 2026
- LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Jun 18, 2020ClinicalTrials.gov NCT04328077 · fetched Nov 12, 2026